![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Bukow Simone C Daffertshofer Michael Hennerici Michael G
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.7, Iss.1, 2006-01, pp. : 73-79
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fibrinolytic treatment for acute ischaemic stroke
By Mazumdar Avi Derdeyn Colin P
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 3, 2006-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical treatment of ischaemic stroke: present and future
By Fieschi C. Cavalletti C. Montinaro E.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Increasing alteplase treatment for ischaemic stroke economical
Inpharma, Vol. 1, Iss. 1519, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Increasing alteplase treatment for ischaemic stroke economical
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. :